Last news
Vivoryon Therapeutics N.V. to Present at the 2023 BIO CEO &

Vivoryon Therapeutics N.V. to Present at the 2023 BIO CEO &

Vivoryon Therapeutics N.V. to Present at the 2023 BIO CEO & Investor Conference Halle (Saale) / Munich, Germany, February 3, 2022 – Vivoryon......

Top Skateboarders Converge on Sharjah UAE for World

Top Skateboarders Converge on Sharjah UAE for World

California Skateparks-designed Aljada Skatepark hosts world's best on their road to Paris.......

Stellantis to Announce Full Year 2022 Results on February

Stellantis to Announce Full Year 2022 Results on February

Stellantis to Announce Full Year 2022 Results on February 22 AMSTERDAM, February 3, 2023 - Stellantis N.V. announced today that its Full Year 2022......

Bergman & Beving acquires A.T.E. Solutions

Bergman & Beving acquires A.T.E. Solutions

Press release Bergman & Beving acquires A.T.E. Solutions Bergman & Beving has today acquired A.T.E. Solutions Ltd. A.T.E produce and......

Monte Rosa Therapeutics to Present at Upcoming Investor

Monte Rosa Therapeutics to Present at Upcoming Investor

BOSTON, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a biotechnology company developing novel molecular glue degrader......

Celldex Therapeutics Announces Upcoming Presentation of

Celldex Therapeutics Announces Upcoming Presentation of

Company to host webcast on Sunday, February 26 at 4:00 pm CT/5:00 pm ET......

Regulatory filing for house dust mite allergy tablet

Regulatory filing for house dust mite allergy tablet

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that its Biologics License Application (BLA) for its house dust mite (HDM) sublingual allergy......

1 ... 915 916 917 918 919 920 921 922 923 ... 981
menu
menu